AI assistant
Sending…
ArcticZymes Technologies — Director's Dealing 2010
Aug 24, 2010
3538_dirs_2010-08-24_88643a69-2a35-41dd-a198-ab8976e571f7.html
Director's Dealing
Open in viewerOpens in your device viewer
Meldepliktig handel
VP Finance & Administration Arvid Vangen har i dag
kjøpt 5.000 aksjer i selskapet til en kurs på kr 5,00
per aksje. Arvid Vangen og nærstående har etter dette
kjøpet 75.233 aksjer og 72.500 opsjoner i Biotec
Pharmacon ASA.
More from ArcticZymes Technologies
Interim / Quarterly Report
2026
May 7
Call Transcript
2026
May 7
Regulatory Filings
2026
May 7
Interim / Quarterly Report
2026
May 7
AGM Information
2026
May 6
AGM Information
2026
May 6
Investor Presentation
2026
May 4
Environmental & Social Information
2026
Apr 30
Annual Report
2026
Apr 30
Annual Report
2026
Apr 30